Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasma membrane phospholipids are a class of amphipathic molecules consisting of hydrophilic phosphate headgroups and hydrophobic fatty acid tails. They spontaneously form bilayer structures in aqueous environments, providing the essential barrier between the cell interior and exterior. The major types include phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, and sphingomyelin. These molecules control membrane fluidity, selective permeability, and serve as platforms for cell signaling by anchoring proteins and organizing membrane domains. Changes in their composition or metabolism can impact a variety of cellular processes and are associated with disease states, but they do not function as druggable targets in the manner of receptors, transporters, or enzymes.
Membrane disruption Modulation of membrane fluidity Interfering with ion transport
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma membrane phospholipid (None).